Andrew Tapper to Small Cell Lung Carcinoma
This is a "connection" page, showing publications Andrew Tapper has written about Small Cell Lung Carcinoma.
Connection Strength
0.044
-
Improgo MR, Johnson CW, Tapper AR, Gardner PD. Bioluminescence-based high-throughput screen identifies pharmacological agents that target neurotransmitter signaling in small cell lung carcinoma. PLoS One. 2011; 6(9):e24132.
Score: 0.023
-
Improgo MR, Schlichting NA, Cortes RY, Zhao-Shea R, Tapper AR, Gardner PD. ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus. Mol Cancer Res. 2010 Feb; 8(2):194-203.
Score: 0.021